Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001628280-21-000427
Filing Date
2021-01-13
Accepted
2021-01-13 13:59:41
Documents
7
Reference 429
333-233865

Document Format Files

Seq Description Document Type Size
1 F-3 innate-formfx3xinnatepharm.htm F-3 560294
2 EX-3.1 exh_31.htm EX-3.1 243944
3 EX-23.1 exh_231.htm EX-23.1 2715
4 EX-5.1 exh_51.htm EX-5.1 37010
5 image_11.jpg GRAPHIC 117036
6 image_01.jpg GRAPHIC 36302
7 pipe1.jpg GRAPHIC 166640
  Complete submission text file 0001628280-21-000427.txt   1282521
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-252074 | Film No.: 21525785
SIC: 2836 Biological Products, (No Diagnostic Substances)